Table 5 Number of patients experiencing common adverse Events (>1% of Population)
Preferred Term | HMWHA | XLHA |
|---|---|---|
N = 146 (%) | N = 139 (%) | |
Diarrhoea | 3 (2.1) | 1 (0.7) |
Dyspepsia | 1 (0.7) | 2 (1.4) |
Injection site pruritus | 2 (1.4) | 1 (0.7) |
Pain | 1 (0.7) | 4 (2.9) |
Pyrexia | 0 (0) | 3 (2.2) |
Cystitis | 2 (1.4) | 2 (1.4) |
Nasopharyngitis | 3 (2.1) | 7 (5) |
Upper respiratory tract infection | 0 (0) | 3 (2.2) |
Joint swelling | 0 (0) | 2 (1.4) |
Musculoskeletal pain | 0 (0) | 2 (1.4) |
Pain in extremity | 6 (4.1) | 3 (2.2) |
Plantar fasciitis | 0 (0) | 2 (1.4) |
Headache | 5 (3.4) | 1 (0.7) |
Paraesthesia | 0 (0) | 2 (1.4) |
Cough | 3 (2.1) | 0 (0) |
Erythema | 0 (0) | 2 (1.4) |